Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab-Reference-Cited by-同舟云学术

Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab

Published:2021-12-29 Issue:2 Volume:74 Page:259-267
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Coates Laura C.¹^ORCID,Abraham Sonya²,Tillett William³,Mease Philip J.⁴^ORCID,Ramiro Sofia⁵^ORCID,Wu Tianshuang⁶,Wang Xin⁶,Pangan Aileen L.⁶,Song In‐Ho⁶

Affiliation:

1. University of Oxford Oxford UK

2. National Institute for Health Research/Wellcome CRF, Imperial College Healthcare NHS Trust London UK

3. Royal National Hospital for Rheumatic Diseases, Pharmacy and Pharmacology University of Bath Bath UK

4. Swedish Medical Center/Providence St. Joseph Health and University of Washington Seattle

5. Leiden University Medical Center, Leiden, and Zuyderland Medical Center Heerlen The Netherlands

6. AbbVie North Chicago Illinois

Funder

AbbVie

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24442

Reference28 articles.

1. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

2. Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis

3. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis

4. Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis

5. Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral spondyloarthritis: What have we learned?;Best Practice & Research Clinical Rheumatology;2023-09

2. Researchers in rheumatology should avoid categorization of continuous predictor variables;BMC Medical Research Methodology;2023-04-26

3. Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial;The Journal of Rheumatology;2022-11-15

4. How Should We Measure Peripheral Spondyloarthritis?;The Journal of Rheumatology;2021-11-01